Improvement of endothelial and renal function with combination of an angiotensin II receptor blocker and statin in hypertensive patients with dyslipidemia

被引：0
|
作者：
Villevalde, S. [1 ]
Mirilashvili, T. [1 ]
Kotovskaya, Y. [1 ]
Kobalava, Z. [1 ]
机构：
[1] Russian Peoples Frienship Univ, Moscow, Russia
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S527 / S527
页数：1
相关论文
共 50 条
  • [21] Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients
    Yamada, Harutaka
    Suga, Norihiro
    Maeda, Kunihiro
    Kimura, Yukihiro
    Miura, Naoto
    Futenma, Arao
    Imai, Hirokazu
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (02): : 64 - 70
  • [22] Effect of calcium channel blocker in combination with an angiotensin II receptor blocker in Japanese patients with hypertension
    Saruta, Takao
    DRUGS, 2006, 66 : 19 - 21
  • [23] Effects of angiotensin II-Receptor blocker, valsartan, on residual renal function in patients on CAPD.
    Kikuta, T
    Watanabe, Y
    Kanno, Y
    Tomori, K
    Nakamoto, H
    Okada, H
    Suzuki, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 482A - 482A
  • [24] COMBINATION THERAPY WITH THE CALCIUM CHANNEL BLOCKER AZELNIDIPINE AND ANGIOTENSIN II RECEPTOR BLOCKERS DECREASES OXIDATIVE STRESS, RENAL AND ATHEROSCLETORIC MARKERS IN ESSENTIAL HYPERTENSIVE PATIENTS
    Yamagishi, T.
    Omata, K.
    JOURNAL OF HYPERTENSION, 2009, 27 : S130 - S130
  • [25] The effect of long-term angiotensin receptor blocker administration on improvement in diastolic function in hypertensive patients with diastolic dysfunction
    Mizuno, T.
    Fukuta, S.
    Nakano, Y.
    Mukai, K.
    Takashima, H.
    Amano, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 622 - 622
  • [26] Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients
    Satoh, Michihiro
    Hirose, Takuo
    Satoh, Hironori
    Nakayama, Shingo
    Obara, Taku
    Murakami, Takahisa
    Muroya, Tomoko
    Asayama, Kei
    Kikuya, Masahiro
    Mori, Takefumi
    Imai, Yutaka
    Ohkubo, Takayoshi
    Metoki, Hirohito
    JOURNAL OF HYPERTENSION, 2022, 40 (08) : 1564 - 1576
  • [27] Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis
    Mortensen, Eric M.
    Restrepo, Marcos I.
    Copeland, Laurel A.
    Pugh, Jacqueline A.
    Anzueto, Antonio
    Cornell, John E.
    Pugh, Mary Jo V.
    PHARMACOTHERAPY, 2007, 27 (12): : 1619 - 1626
  • [28] Efficacy and safety of angiotensin II receptor blocker in elderly isolated systolic hypertensive patients
    Saito, Ikuo
    Kushiro, Toshio
    Sato, Yuki
    Harada, Ken-ichi
    Kobayashi, Fumiaki
    Sagawa, Kei
    Hiramatsu, Katsutoshi
    JOURNAL OF HYPERTENSION, 2006, 24 : 378 - 378
  • [29] Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus
    Karashima, Shigehiro
    Yoneda, Takashi
    Kometani, Mitsuhiro
    Ohe, Masashi
    Mori, Shunsuke
    Sawamura, Toshitaka
    Furukawa, Kenji
    Yamagishi, Masakazu
    Takeda, Yoshiyu
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2016, 38 (07) : 565 - 570
  • [30] Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients
    Sardo, Maria A.
    Mandraffino, Giuseppe
    Riggio, Stefania
    D'Ascola, Angela
    Alibrandi, Angela
    Saitta, Carlo
    Imbalzano, Egidio
    Castaldo, Maria
    Cinquegrani, Maurizio
    Saitta, Antonino
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (09) : 933 - 938
12345